Literature DB >> 16674917

Sphingosine-1-phosphate stimulates rat primary chondrocyte proliferation.

Mi-Kyoung Kim1, Ha Young Lee, Jong-Young Kwak, Joo-In Park, Jeanho Yun, Yoe-Sik Bae.   

Abstract

Rat primary chondrocytes express the sphingosine-1-phosphate (S1P) receptor, S1P(2), S1P(3), S1P(4), but not S1P(1). When chondrocytes were stimulated with S1P or phytosphingosine-1-phosphate (PhS1P, an S1P(1)- and S1P(4)-selective agonist), phospholipase C-mediated cytosolic calcium increase was dramatically induced. S1P and PhS1P also stimulated two kinds of mitogen-activated protein kinases, extracellular signal-regulated kinase (ERK) and p38 kinase in chondrocytes. In terms of the two phospholipids-mediated functional modulation of chondrocytes, S1P and PhS1P stimulated cellular proliferation. The two phospholipids-induced chondrocyte proliferations were almost completely blocked by PD98059 but not by SB203580, suggesting that ERK but not p38 kinase is essentially required for the proliferation. Pertussis toxin almost completely inhibited the two phospholipids-induced cellular proliferation and ERK activation, indicating the crucial role of G(i) protein. This study demonstrates the physiological role of two important phospholipids (S1P and PhS1P) on the modulation of rat primary chondrocyte proliferation, and the crucial role played by ERK in the process.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16674917     DOI: 10.1016/j.bbrc.2006.04.042

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

Review 1.  Sphingosine-1-phosphate: a potential therapeutic target for rheumatoid arthritis.

Authors:  Peng-fei Hu; Yi Chen; Peng-fei Cai; Li-feng Jiang; Li-dong Wu
Journal:  Mol Biol Rep       Date:  2010-11-30       Impact factor: 2.316

Review 2.  Sphingolipid metabolism and its role in the skeletal tissues.

Authors:  Zohreh Khavandgar; Monzur Murshed
Journal:  Cell Mol Life Sci       Date:  2014-11-26       Impact factor: 9.261

3.  Mechanism of glycosaminoglycan-mediated bone and joint disease: implications for the mucopolysaccharidoses and other connective tissue diseases.

Authors:  Calogera M Simonaro; Marina D'Angelo; Xingxuan He; Efrat Eliyahu; Nataly Shtraizent; Mark E Haskins; Edward H Schuchman
Journal:  Am J Pathol       Date:  2007-12-13       Impact factor: 4.307

4.  The immunosuppressant FTY720 (fingolimod) enhances glycosaminoglycan depletion in articular cartilage.

Authors:  Martin H Stradner; Hannes Angerer; Thomas Ortner; Florentine C Fuerst; Daniela Setznagl; Marie-Luise Kremser; Josef Hermann; Winfried B Graninger
Journal:  BMC Musculoskelet Disord       Date:  2011-12-12       Impact factor: 2.362

5.  Sphingosine-1-phosphate attenuates proteoglycan aggrecan expression via production of prostaglandin E2 from human articular chondrocytes.

Authors:  Kayo Masuko; Minako Murata; Hiroshi Nakamura; Kazuo Yudoh; Kusuki Nishioka; Tomohiro Kato
Journal:  BMC Musculoskelet Disord       Date:  2007-03-20       Impact factor: 2.362

Review 6.  Lipid Metabolism in Cartilage Development, Degeneration, and Regeneration.

Authors:  Zhanpeng Su; Zhixian Zong; Jinxia Deng; Jianping Huang; Guihua Liu; Bo Wei; Liao Cui; Gang Li; Huan Zhong; Sien Lin
Journal:  Nutrients       Date:  2022-09-25       Impact factor: 6.706

7.  Sphingosine 1-phosphate counteracts the effects of interleukin-1β in human chondrocytes.

Authors:  Martin H Stradner; Gerald Gruber; Hannes Angerer; Verena Huber; Daniela Setznagl; Marie-Luise Kremser; Florentine C Moazedi-Fürst; Reinhard Windhager; Winfried B Graninger
Journal:  Arthritis Rheum       Date:  2013-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.